Myelofibrosis Treatment Option

[hunter5582]

Just saw this Webinar announced. Thought it might be of interest to some. Note that it is sponsored by a pharmaceutical company, so will likely focus on something they have in development.

Welcome to this live expert webinar, sponsored by Bristol-Myers Squibb.

Topics of discussion at this virtual event include:

• Clinical data supporting a treatment option for patients with intermediate-2 or high-risk myelofibrosis

• NCCN Clinical Practice Guidelines surrounding use of a treatment option in myelofibrosis

• Safety, adverse event management, and dose modifications

• Steps for starting your patients on this treatment option

Amit A Patel, M.D., AACP

Hudson Hematology Oncology, LLC

American Infusion Center, LLC

globalmeet.webcasts.com/sta...

[Cja1956]

Thank you, Hunter. I will definitely watch this.

[RobinBrum]

UK time puts this at Midnight on Wednesday. I wonder if there will be a chance to view the recording?

[hunter5582 in reply to RobinBrum]

I tried to log an and see, but could not find out. Hopefully it will get posted.